CC BY-NC-ND 4.0 · Indian J Plast Surg 2021; 54(03): 308-313
DOI: 10.1055/s-0041-1734574
Original Article

Evaluation of Serum Levels of Procalcitonin and C-Reactive Protein as Prognostic Indicators in Burns

Aparna Sinha
1   Department of Plastic Surgery, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India
,
Mukesh Kumar Sharma
2   Department of Burns, Plastic and Reconstructive Surgery, PGIMER and Dr. R. M. L. Hospital, New Delhi, India
,
Komal Tripathi
2   Department of Burns, Plastic and Reconstructive Surgery, PGIMER and Dr. R. M. L. Hospital, New Delhi, India
,
Nandini Duggal
3   Department of Microbiology, PGIMER and Dr. R. M. L. Hospital, New Delhi, India
,
Vinay Kumar Tiwari
4   Department of Burns, Plastic and Reconstructive Surgery, VMMC and Safdarjung Hospital, New Delhi, India
› Author Affiliations
Funding Source None.

Abstract

Background Burn is a leading cause of fatality in a developing country. C-reactive protein levels (CRP) and procalcitonin (PCT) can be prognostic indicators for the burn patients' mortality.

Aim To assess serial levels of serum PCT and serum CRP as prognostic indicators in burns.

Patient and Methods In patients admitted with burns, alternate-day serum PCT and CRP were measured from the time of admission until the time of discharge or until survival. The change in trends of CRP and PCT serum levels were studied, and it was then correlated with mortality among these burn patients.

Results The first-day value of serum PCT > 1772 pg/mL and serum CRP > 71 mg/mL or any value of serum PCT > 2163 pg/mL and of serum CRP > 90 mg/L indicate a poor prognosis in burns.

Conclusions The day-1 values of PCT and CRP were significantly higher in nonsurvivors than survivors in burns. The increasing trends of serum PCT and CRP levels are independent predictors of mortality in burns requiring prompt intervention. Rising PCT and CRP level denote poor prognosis in burns with an increased likelihood of death by 4.5 and 23.6 times, respectively.



Publication History

Article published online:
02 September 2021

© 2021. Association of Plastic Surgeons of India. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Tobiasen J, Hiebert JM, Edlich RF. The abbreviated burn severity index. Ann Emerg Med 1982; 11 (05) 260-262
  • 2 Bargues L, Chancerelle Y, Catineau J, Jault P, Carsin H. Evaluation of serum procalcitonin concentration in the ICU following severe burn. Burns 2007; 33 (07) 860-864
  • 3 Neely AN, Fowler LA, Kagan RJ, Warden GD. Procalcitonin in pediatric burn patients: an early indicator of sepsis?. J Burn Care Rehabil 2004; 25 (01) 76-80
  • 4 Li Q, Gong X. Clinical significance of the detection of procalcitonin and C-reactive protein in the intensive care unit. Exp Ther Med 2018; 15 (05) 4265-4270
  • 5 Meng FS, Su L, Tang YQ, Wen Q, Liu YS, Liu ZF. Serum procalcitonin at the time of admission to the ICU as a predictor of short-term mortality. Clin Biochem 2009; 42 (10-11) 1025-1031
  • 6 Ryan CM, Schoenfeld DA, Thorpe WP, Sheridan RL, Cassem EH, Tompkins RG. Objective estimates of the probability of death from burn injuries. N Engl J Med 1998; 338 (06) 362-366
  • 7 Schneider HG, Lam QT. Procalcitonin for the clinical laboratory: a review. Pathology 2007; 39 (04) 383-390
  • 8 Mann EA, Wood GL, Wade CE. Use of procalcitonin for the detection of sepsis in the critically ill burn patient: a systematic review of the literature. Burns 2011; 37 (04) 549-558
  • 9 Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006; 34 (07) 1996-2003
  • 10 Ahuja RB, Bhattacharya S, Rai A. Changing trends of an endemic trauma. Burns 2009; 35 (05) 650-656
  • 11 Ahuja RB, Bhattacharya S, Rai A. Changing trends of an endemic trauma. Burns 2009; 35 (05) 650-656
  • 12 Sharma BR, Harish D, Singh VP, Bangar S. Septicemia as a cause of death in burns: an autopsy study. Burns 2006; 32 (05) 545-549
  • 13 Kumar A, Roberts D, Wood KE. et al Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34 (06) 1589-1596
  • 14 Bone RC, Balk RA, Cerra FB. et al The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101 (06) 1644-1655
  • 15 Barati M, Alinejad F, Bahar MA. et al Comparison of WBC, ESR, CRP and PCT serum levels in septic and non-septic burn cases. Burns 2008; 34 (06) 770-774
  • 16 Piroglu DI, Tulgar S, Piroglu MD. et al Do early procalcitonin levels aid in predicting mortality in burn patients?. Int J Clin Exp Med 2016; 9 (03) 6497-6503
  • 17 Kim HS, Yang HT, Hur J. et al Procalcitonin levels within 48 hours after burn injury as a prognostic factor. Ann Clin Lab Sci 2012; 42 (01) 57-64
  • 18 von D Heimburg, Stieghorst W, Khorram-Sefat R, Pallua N. Procalcitonin–a sepsis parameter in severe burn injuries. Burns 1998; 24 (08) 745-750
  • 19 Pruchniewski D, Pawlowski T, Morkowski J, Mackiewicz S. C-reactive protein in management of children’s burns. Ann Clin Res 1987; 19 (05) 334-338